Table 2 Medication use in cases of incident sarcoidosis
From: Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study
N (%) | Mean time from diagnosis to first treatment (days) | |
|---|---|---|
Systemic steroid | 2340 (78.0) | 49.0 (85.9) |
prednisolone | 1666 (55.6) | 44.7 (81.9) |
methylprednisolone | 885 (29.5) | 106.9 (113.8) |
dexamethasone | 659 (22.0) | 153.5 (110.2) |
use for > 30 days | 1527 (50.9) | 19.4 (45.6) |
Topical steroid | 627 (20.9) | 155.5 (114.7) |
hydrocortisone | 180 (6.0) | 172.2 (110.6) |
betamethasone | 159 (5.3) | 172.0 (112.6) |
methylprednisolone | 148 (4.9) | 125.9 (120.3) |
Other immunosuppressant | 263 (8.8) | 96.5 (109.7) |
methotrexate | 131 (4.4) | 91.7 (104.2) |
cyclosporin | 85 (2.8) | 130.2 (117.3) |
azathioprine | 72 (2.4) | 99.1 (112.0) |
use for > 30 days | 180 (6.0) | 69.5 (85.9) |
Hydroxychloroquine | 123 (4.1) | 50.3 (86.6) |
use for > 30 days | 97 (3.2) | 47.3 (80.6) |
None | 575 (19.2) |